VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MEDP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MEDPMedpace Holdings, Inc.
$527.07$15.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMEDPQuarterly Financials

Medpace Holdings, Inc. (MEDP) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Medpace Holdings, Inc. (MEDP) quarterly income statement — complete revenue, gross profit & net income history

MEDP Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue706.6M708.45M659.9M603.31M558.57M536.59M533.32M528.1M511.04M498.4M492.5M460.87M
Revenue Growth %26.5%32.03%23.74%14.24%9.3%7.66%8.29%14.59%17.73%26.47%28.34%31.22%
Cost of Goods Sold510.28M503.13M462.96M423.3M380.22M358.27M364.31M374.27M355.9M361.6M359.31M336.55M
COGS % of Revenue72.22%71.02%70.16%70.16%68.07%66.77%68.31%70.87%69.64%72.55%72.96%73.03%
Gross Profit196.33M205.32M196.94M180.01M178.35M178.32M169.01M153.84M155.14M136.81M133.19M124.32M
Gross Margin %27.78%28.98%29.84%29.84%31.93%33.23%31.69%29.13%30.36%27.45%27.04%26.97%
Gross Profit Growth %10.08%15.14%16.53%17.01%14.96%30.34%26.89%23.75%19.17%18.21%11.89%25.58%
Operating Expenses54.82M52.05M55.13M53.68M64.83M52.94M56.73M48.69M51.07M49.49M48.28M45.92M
OpEx % of Revenue7.76%7.35%8.35%8.9%11.61%9.87%10.64%9.22%9.99%9.93%9.8%9.96%
Selling, General & Admin47.92M44.92M48.08M46.66M57.9M45.43M49.22M41.45M44.08M42.51M41.41M39.4M
SG&A % of Revenue6.78%6.34%7.29%7.73%10.37%8.47%9.23%7.85%8.63%8.53%8.41%8.55%
Research & Development000000000000
R&D % of Revenue------------
Other Operating Expenses1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Operating Income141.5M153.27M141.81M126.33M113.52M125.38M112.27M105.15M104.07M87.32M84.91M78.39M
Operating Margin %20.03%21.63%21.49%20.94%20.32%23.37%21.05%19.91%20.36%17.52%17.24%17.01%
Operating Income Growth %24.65%22.25%26.31%20.15%9.08%43.58%32.23%34.13%20.72%14.25%9.1%30.14%
EBITDA148.41M160.4M148.86M119.41M120.45M132.88M119.79M112.39M111.06M94.29M91.79M84.91M
EBITDA Margin %21%22.64%22.56%19.79%21.56%24.76%22.46%21.28%21.73%18.92%18.64%18.42%
EBITDA Growth %23.21%20.71%24.26%6.25%8.46%40.93%30.51%32.35%20.51%14.53%9.77%29.08%
D&A (Non-Cash Add-back)6.91M7.13M7.05M-6.93M6.93M7.51M7.52M7.24M6.99M6.97M6.88M6.52M
EBIT141.5M156.83M142.84M124.54M113.52M125.38M112.27M105.15M104.07M89.52M84.91M78.39M
Net Interest Income5.12M01.52M1.08M6.46M7.88M7.53M5.46M4.12M1.84M-105K-1.37M
Interest Income5.12M01.52M1.08M6.46M7.88M7.53M5.46M4.12M1.84M00
Interest Expense0000000000105K1.37M
Other Income/Expense6.09M3.56M1.03M-1.8M4.65M8.5M6.5M5.33M8.71M3.39M-1.71M-2.65M
Pretax Income147.59M156.83M142.84M124.54M118.17M133.88M118.78M110.48M112.78M90.71M83.2M75.74M
Pretax Margin %20.89%22.14%21.64%20.64%21.16%24.95%22.27%20.92%22.07%18.2%16.89%16.44%
Income Tax23.72M21.7M31.7M34.28M3.58M16.86M22.35M22.13M10.19M12.41M12.65M14.68M
Effective Tax Rate %16.07%13.84%22.19%27.52%3.03%12.6%18.82%20.03%9.04%13.68%15.21%19.38%
Net Income123.87M135.13M111.14M90.26M114.59M117.02M96.43M88.35M102.59M78.3M70.55M61.07M
Net Margin %17.53%19.07%16.84%14.96%20.52%21.81%18.08%16.73%20.07%15.71%14.32%13.25%
Net Income Growth %8.09%15.48%15.25%2.16%11.7%49.45%36.68%44.68%40.74%14.02%6.85%23.72%
Net Income (Continuing)123.87M135.13M111.14M90.26M114.59M117.02M96.43M88.35M102.59M78.3M70.55M61.07M
Discontinued Operations000000000000
Minority Interest000000000000
EPS (Diluted)4.284.673.873.103.673.673.012.753.202.462.221.93
EPS Growth %16.62%27.25%28.57%12.73%14.69%49.19%35.59%42.49%40.97%16.59%8.29%32.19%
EPS (Basic)4.354.783.953.163.773.783.112.853.322.552.302.00
Diluted Shares Outstanding28.96M28.96M29.71M30.16M31.2M32.01M32.09M32.09M32M31.82M31.76M31.57M
Basic Shares Outstanding28.45M28.29M29.03M29.49M30.39M30.95M31.05M30.99M30.84M30.72M30.63M30.54M
Dividend Payout Ratio------------